301509SZSE

Jinkai Biotech Co., Ltd.

金凯生科

301509

Shenzhen Stock Exchange

Follow
38 announcements tracked· Last: May 25, 2026

Key Financials

Revenue¥148.1M
Net Profit¥16.6M
ROE0.75%
Debt Ratio5.00%
Monetary Funds¥405.5M
Receivables¥120.0M
Total Shares120.4M

Announcements

38 total

Announcement on the Implementation of 2025 Annual Equity Distribution

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Pre-Disclosure of Shareholder Share Reduction

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Legal Opinion on the 2025 Shareholders' Meeting of Jinkai (Liaoning) Life Science Co., Ltd. by Zhonglun Law Firm (Beijing)

Share PledgeShareholding Change DisclosureCapital Reduction

Announcement of Shareholders' Meeting Resolutions for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Tracking Report from CITIC Jinshi Securities Co., Ltd. on Jinkai (Liaoning) Life Science Co., Ltd. for 2025

Shareholder Share IncreaseShare PledgeShareholding Change Disclosure

Verification opinion from CITIC Securities Co., Ltd. on the extension of certain raised fund investment projects by Jinkai (Liaoning) Life Science Technology Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

Special verification report from CITIC Securities Co., Ltd. on the storage, management, and use of raised funds by Jinkai (Liaoning) Life Science Technology Co., Ltd. for the year 2025

Share Repurchase CompletionShareholder Share IncreaseShare Pledge

Announcement on the reappointment of the company's auditing institution for the year 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the compensation plan for directors and senior management for the year 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Board of directors' work report for the year 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Independent director work report for the year 2025 (Liu Yuanyuan)

Convertible BondsShareholding Change DisclosureCapital Reduction

Independent director work report for the year 2025 (You Song)

Convertible BondsShareholding Change DisclosureCapital Reduction

Independent director work report for the year 2025 (Guo Yukun)

Convertible BondsShareholding Change DisclosureCapital Reduction

Announcement on holding an online performance briefing for the year 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Verification opinion from CITIC Securities Co., Ltd. on the internal control evaluation report of Jinkai (Liaoning) Life Science Technology Co., Ltd. for the year 2025

Share Repurchase CompletionShareholder Share IncreaseShare Pledge

Internal control audit report of Jinkai (Liaoning) Life Science Technology Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

Internal control evaluation report for the year 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Internal control management system (April 2026)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Director and senior management compensation management system (revised in April 2026)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Financial management system (revised in April 2026)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Company's shareholder dividend return plan for the next three years (2026-2028)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the provision for asset impairment for the year 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the extension of certain raised fund investment projects

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notice of the 2025 annual shareholders' meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Resolution announcement of the 11th meeting of the second board of directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the profit distribution plan for the year 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

First quarter report for 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special report on the storage, management, and use of raised funds for the year 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Verification report on the storage, management, and use of raised funds by Jinkai (Liaoning) Life Science Technology Co., Ltd.

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

Evaluation report on the performance of the accounting firm for the year 2025 and the report on the fulfillment of supervisory responsibilities by the audit committee of the board of directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special explanation on non-operating fund occupation and other related fund transactions by Jinkai (Liaoning) Life Science Technology Co., Ltd.

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

Summary table of non-operating fund occupation and other related fund transactions for the year 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special report on the self-examination of the independence of independent directors for the year 2025 by the board of directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Summary of the 2025 annual report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

CITIC Securities Co., Ltd. Regarding the 'Shenzhen Stock Exchange Listed Company Regular On-site Inspection Report'

Shareholder Share IncreaseShare PledgeShareholding Change Disclosure

Announcement on the Expiration of the Share Reduction Plan Period and Reduction Results by Shareholders

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notes & Comments

Sign in to leave a comment or private note.

Loading…